Approval · Notice of Compliance 36124 · 2025
HALOPERIDOL LA: Notice of Compliance 36124
Issued October 5, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36124
- Date
- October 5, 2025
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in the specification for the drug product. Replacement of a primary container closure system
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HALOPERIDOL LA | Not yet assigned | — |
Medicinal ingredients
- HALOPERIDOL DECANOATE 100 MG per ML